Table 3.
Characteristics of the tumor.
| Characteristics n (%) | Premenopausal (n = 6) | Postmenopausal (n = 11) | All (n = 17) |
|---|---|---|---|
| Lesion | |||
| Unilateral | 5 (83.33) | 10 (90.91) | 15 (88.24) |
| Bilateral | 1 (16.67) | 1 (9.09) | 2 (11.76) |
| Histology | |||
| Ductal | 6 (100.00) | 8 (72.73) | 14 (82.35) |
| Othersa | 0 (0.00) | 3 (27.27) | 3 (17.65) |
| Receptor status | |||
| ER+/PR+ | 5 (83.33) | 8 (72.73) | 13 (76.47) |
| TNM status | |||
| 0 | 0 (0.00) | 3 (27.27) | 3 (17.65) |
| 1 | 2 (33.33) | 4 (36.36) | 6 (35.29) |
| 2 | 4 (66.67) | 4 (36.36) | 8 (47.06) |
Abbreviations: ER, estrogen receptor; PR, progesterone receptor.
aIncludes lobular, mucinous, and metaplastic carcinomas.